$NURO News Article - NeuroMetrix Reports that Quell Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial https://marketwirenews.com/news-releases/neur...80107.html
NeuroMetrix Inc. (NURO) Stock Research Links
My Twitter: WhyteStocks